718
Joel Greenhouse
The randomized controlled clinical trial is still a relatively new technology for assessing therapeutic interventions, yet innovations in the design and analysis of clinical trials in psychiatry have lagged behind other areas of the biomedical sciences. In this editorial for the journal Biological Psychiatry we briefly consider some of the reasons why.